Table 1.
Control Chow Group (n = 7) | Atherogenic Diet Group (n = 5) | M-Ath Diet Group (n = 6) | |
---|---|---|---|
Sex, male/female | 2/5 | 0/5 | 0/6 |
Weight at euthanasia, kg | 53 ± 2 | 94 ± 4* | 86 ± 14* |
Mean weight gain, kg | 14 ± 1 | 54 ± 4* | 38 ± 13 |
Glycemic measures | |||
Fasting glucose, mg/dl | 79 ± 3 | 87 ± 2 | 88 ± 6 |
Fasting insulin, μU/ml | 11 ± 2 | 15 ± 1 | 18 ± 3 |
HOMA | 2 ± 0.3 | 3 ± 0.3 | 4 ± 1 |
Lipid measures | |||
Total cholesterol, mg/dl | 81 ± 4 | 328 ± 32* | 629 ± 80*† |
LDL cholesterol, mg/dl | 36 ± 4 | 242 ± 27* | 520 ± 68*† |
HDL cholesterol, mg/dl | 41 ± 4 | 79 ± 6* | 83 ± 5* |
LDL/HDL Ratio | 1 ± 0.2 | 3 ± 0.3* | 6 ± 1*† |
Triglycerides, mg/dl | 24 ± 3 | 37 ± 2 | 130 ± 17*† |
Liver biochemistries | |||
AST, U/l | 32 ± 3 | 27 ± 1 | 100 ± 21*† |
ALT, U/l | 46 ± 7 | 33 ± 1 | 41 ± 12 |
ALP, U/l | 73 ± 11 | 110 ± 10 | 273 ± 110* |
Total bilirubin, mg/dl | 0.2 ± 0.02 | 0.2 ± 0.02 | 0.3 ± 0.04 |
Values expressed are means ± SE.
P < 0.05 vs. control chow group.
P < 0.05 vs. atherogenic diet group.
M-Ath, modified atherogenic; HOMA, homeostatic model assessment method; LDL, low-density lipoprotein; HDL, high-density lipoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase.